Access BridgeGap Ventures Asset Manager Profile - aVenture Research
Access BridgeGap Ventures is a venture capital firm with a focus on early-stage investments, particularly pre-Series A. With a $35 million fund, the firm primarily targets entrepreneurs across the Middle East and North Africa but considers opportunities outside these regions within their core sectors. Their investment strategy emphasizes supporting exceptional leaders from the outset, often as the first institutional investor.
Notable portfolio companies include Elicio Therapeutics, eXIthera Pharmaceuticals, and Novel Therapeutic Technologies. The firm is led by key partners with significant experience in the venture capital space, although specific names are not provided. Access BridgeGap Ventures prides itself on fueling growth and success by investing in people, offering unique value-add services to help portfolio companies thrive.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.